
Loading, please wait...

Loading, please wait...

Atherosclerosis remains a leading cause of cardiovascular mortality globally, with a significant impact on the Indian population. Recent advancements in multi-omics integration have pinpointed four critical atherosclerosis biomarkers—ANXA2, DBN1, ZNF385D, and IL6ST. These genes appear to bridge the gap between endothelial cell dysfunction and the dysregulation of the immune microenvironment. By understanding these molecular links, clinicians may soon have more precise tools for early diagnosis and targeted intervention.
The research utilized a single-cell atlas of atherosclerosis and high-dimensional gene co-expression networks to isolate these hub genes. Scientists narrowed their search from sixty-six endothelial-associated genes to these four core features using sophisticated machine learning models. Furthermore, the analysis revealed that these specific genes correlate strongly with the infiltration of T cells, B cells, and macrophages within atherosclerotic plaques. Consequently, these findings suggest that the local immune response is heavily influenced by endothelial gene expression.
Understanding the role of these atherosclerosis biomarkers provides a clearer picture of plaque progression. Immune infiltration analysis showed a global increase in activated immune cells in lesions, confirming that inflammation drives the disease. Specifically, the study highlighted the binding potential of these biomarkers with existing and natural therapeutic agents. Molecular docking simulations revealed that ANXA2 binds effectively with thalidomide, while IL6ST shows a high affinity for resveratrol.
Moreover, these findings offer a roadmap for future drug development and personalized medicine. Resveratrol, a compound frequently discussed for its cardioprotective benefits, exhibited a strong binding energy of -7.4 kcal/mol with the IL6ST protein. This suggests that targeting these biomarkers could mitigate the inflammatory cascade that leads to severe cardiovascular events. Doctors can now look forward to diagnostic panels that incorporate these markers for better risk stratification.
The study identified ANXA2, DBN1, ZNF385D, and IL6ST as core feature genes that link endothelial cell dysfunction to immune microenvironment changes in atherosclerosis.
These biomarkers correlate significantly with the infiltration of activated T cells, B cells, and macrophages in atherosclerotic lesions, indicating they play a role in local inflammatory dysregulation.
Yes, molecular docking suggests that ANXA2 and IL6ST can bind with thalidomide and resveratrol, respectively, potentially offering new avenues for targeted anti-inflammatory therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have identified four core biomarkers—ANXA2, DBN1, ZNF385D, and IL6ST—that link atherosclerosis progression to immune system dysregulation....
8 months ago

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday